BLPH
Bellerophon Therapeutics (BLPH)
$04
About Bellerophon Therapeutics (BLPH)
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Details
Daily high
$0.04
Daily low
$0.04
Price at open
$0.04
52 Week High
$0.08
52 Week Low
$0.03
Market cap
440,400
Dividend yield
0.00%
Volume
5
Avg. volume
2,076
P/E ratio
-.04
Bellerophon Therapeutics News
Details
Daily high
$0.04
Daily low
$0.04
Price at open
$0.04
52 Week High
$0.08
52 Week Low
$0.03
Market cap
440,400
Dividend yield
0.00%
Volume
5
Avg. volume
2,076
P/E ratio
-.04